Literature DB >> 16183930

Functional CT quantification of tumor perfusion after transhepatic arterial embolization in a rat model.

Zuxing Kan1, Satoshi Kobayashi, Sith Phongkitkarun, Chusilp Charnsangavej.   

Abstract

PURPOSE: To quantify tumor perfusion after transcatheter arterial embolization (TAE) with functional computed tomography (CT) and to validate the reproducibility of quantification measurements.
MATERIALS AND METHODS: This study was conducted in accordance with an institutional animal care and use committee-approved protocol. Sixteen rats with liver tumors underwent TAE with 1 mg (group 1) or 3 mg (group 2) of polyvinyl alcohol particles. In each group, four rats underwent functional CT immediately after TAE (day 0) and four others underwent functional CT 2 days after TAE (day 2). Another four rats served as control rats. Blood flow (BF), blood volume (BV), mean transit time (MTT), and permeability-surface area product were measured by using a functional CT software program. For evaluation of reproducibility, six additional rats with mammary tumors underwent functional CT twice, with examinations 2 hours apart. The mixed-effect model was used to assess the TAE treatment effect, and the Pearson correlation test was used to determine measurement reproducibility.
RESULTS: With the exception of BF in group 1 on day 2 (P = .41), BF and BV values in both groups on both days were significantly lower than BF and BV values in the control rats (with P values ranging from .018 to <.001). BF was significantly lower in group 2 than in group 1 on days 0 and 2 (P = .043 and P = .02, respectively). BV was significantly lower on day 2 than on day 0 in group 2 (P = .016). MTT was generally inversely related to BF. MTTs in group 2 on days 0 and 2 were significantly longer than those in the control rats (P < .001 and P = .03, respectively), and MTT was shorter on day 2 than on day 0 in group 2 (P = .02). Permeability-surface area product changes were similar to BF changes. There were no significant differences (P values ranged from .2 to .5) between perfusion parameters in the reproducibility study.
CONCLUSION: The results of this study validate the use of functional CT in the quantification of tumor perfusion after TAE and the reproducibility of such quantification measurements. RSNA, 2005

Entities:  

Mesh:

Year:  2005        PMID: 16183930     DOI: 10.1148/radiol.2371040526

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

1.  Perfusion CT assessment of tissue hemodynamics following hepatic arterial infusion of increasing doses of angiotensin II in a rabbit liver tumor model.

Authors:  Kenneth C Wright; Murali K Ravoori; Katherine A Dixon; Lin Han; Sheela P Singh; Ping Liu; Sanjay Gupta; Valen E Johnson; Zuxing Kan; Vikas Kundra
Journal:  Radiology       Date:  2011-06-01       Impact factor: 11.105

2.  Dynamic contrast-enhanced micro-CT on mice with mammary carcinoma for the assessment of antiangiogenic therapy response.

Authors:  Fabian Eisa; Robert Brauweiler; Martin Hupfer; Tristan Nowak; Laura Lotz; Inge Hoffmann; David Wachter; Ralf Dittrich; Matthias W Beckmann; Gregor Jost; Hubertus Pietsch; Willi A Kalender
Journal:  Eur Radiol       Date:  2011-11-10       Impact factor: 5.315

3.  Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.

Authors:  Davide Ippolito; Cristina Capraro; Alessandra Casiraghi; Cristina Cestari; Sandro Sironi
Journal:  Eur Radiol       Date:  2011-11-16       Impact factor: 5.315

4.  Treatment Response After Unusual Low Dose Sorafenib: Diagnosis with Perfusion CT and Follow-up in a Patient with Recurrent Hepatocellular Carcinoma.

Authors:  Rodolfo Sacco; Lorenzo Faggioni; Irene Bargellini; Antonio Romano; Marco Bertini; Barbara Ginanni; Valentina Battaglia; Michele Bertoni; Elena Bozzi; Graziana Federici; Salvatore Metrangolo; Giuseppe Parisi; Emanuele Neri; Elisabetta Sodini; Emanuele Tumino; Giampaolo Bresci; Carlo Bartolozzi
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 5.  Clinical application of hepatic CT perfusion.

Authors:  Liang Zhong; Wen-Jing Wang; Jian-Rong Xu
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

6.  Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model.

Authors:  Jia-Yan Ni; Lin-Feng Xu; Wei-Dong Wang; Qiao-Sheng Huang; Hong-Liang Sun; Yao-Ting Chen
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-16       Impact factor: 4.553

Review 7.  Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, mRECIST, and Others.

Authors:  Mecit Kantarci; Berhan Pirimoglu
Journal:  J Gastrointest Cancer       Date:  2017-09

8.  Perfusion measurements by micro-CT using prior image constrained compressed sensing (PICCS): initial phantom results.

Authors:  Brian E Nett; Robert Brauweiler; Willi Kalender; Howard Rowley; Guang-Hong Chen
Journal:  Phys Med Biol       Date:  2010-04-01       Impact factor: 3.609

9.  Correlation of histological findings from a large ciliochoroidal melanoma with CT perfusion and 3T MRI dynamic enhancement studies.

Authors:  Jose S Pulido; Norbert G Campeau; Ernst Klotz; Andrew N Primak; Osama Saba; Kaan Gunduz; Herbert Cantrill; Diva Salomão; Cynthia H McCollough
Journal:  Clin Ophthalmol       Date:  2008-06

10.  Vasomodulation of tumor blood flow: effect on perfusion and thermal ablation size.

Authors:  Hanping Wu; Agata A Exner; Tianyi M Krupka; Brent D Weinberg; John R Haaga
Journal:  Ann Biomed Eng       Date:  2008-12-16       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.